• Free shipping over $99.00 using Canada Post and Same Day delivery services
    • English En
    • Français Fr
  • Free shipping over $99.00 using Canada Post and Same Day delivery services
    • English En
    • Français Fr
CBD Health Science Strains THC

What Science Says About CBD and Anxiety

What Science Says About CBD and Anxiety

Cannabis contains over 100 cannabinoids and up to 200 terpenes, with THC and CBD being popular cannabinoids that most people have heard about. While scientific studies have shown both THC and CBD have possible medical benefits, this article will focus more on CBD’s potential benefits in treating anxiety by citing and observing the most relevant and recent scientific research 

Acute Doses of CBD and Subjective Anxiety  

Several independent studies have shown that acute doses of CBD (300 – 600 mg) reduce subjective anxiety in people who had generalized anxiety disorder or in participants who were asked to give an impromptu speech .1-4  

Moreover, CBD’s anxiolytic or anxiety-reducing effects were shown to be similar to known anxiolytic drug, Ipsapirone, in healthy participants who were required to give an impromptu speech as part of their study.4  


Survey on CBD Usage 

From a survey of 387 respondents asked about their CBD use, 42.6% supported CBD for treating their self-perceived anxiety.5  

86.5% of respondents who supported CBD for their self-perceived anxiety reported that they felt less anxious and 58.9% thought about their problems less when trying to relax.5 Respondents who used CBD for treating their self-reported anxiety had lower odds of using CBD in the evenings and were associated with consuming sublingually (dosing under the tongue).  

It should also be noted that women had greater odds of using CBD for treating their self-perceived anxiety than males. The age groups of 35-54 years and 55+ years old had lower odds of using CBD for treating self-perceived anxiety in comparison to the 18-34- year-old respondent group.5  

Though not specific to anxiety, more than half of the 387 respondents reported using a daily dose of less than 50 mg CBD via a sublingual route of administration and most people had been using CBD for 3- 12 months (67.6%).5 


Results of a MedReleaf survey  

A MedReleaf® survey found that the following strains were self-reported by patients (n=69) as being helpful in treating their anxiety.6  

  1. Luminarium(high THC): 30.4% responded that Luminarium was most helpful in treating their anxiety  
  2. Midnight (balanced THC: CBD): 27.5% responded that Midnight was most helpful in treating their anxiety  
  3. Avidekel™ (high CBD): 21.7% responded that Avidekel was most helpful in treating their anxiety 


New Aurora publication 

In a study published this month in Frontiers of Public Health, the analysis of MedReleaf patient survey data showed that patients who reported using cannabis to treat their anxiety experienced significant improvements in their overall quality of life after 6 weeks of treatment.7

Additionally, 85% of these patients reported they felt they had some improvement in their anxiety.7 32% of these patients identified high CBD products as being helpful to treat their anxiety.7 

In Conclusion

At Aurora®, we always stay up to date on the latest scientific research surrounding the effectiveness of medical cannabis. We hope this information has been helpful to you in making the most well-informed decisions for your health and wellness.   


  1. Bergamaschi MM, Queiroz RHC, Chagas MHN, de Oliveira DCG, De Martinis BS, Kapczinski F, Quevedo J, Roesler R, Schröder N, Nardi AE, Martín-Santos R, Hallak JEC, Zuardi AW, Crippa JAS. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology. 2011;36(6):1219-1226.  
  1. Crippa J, Derenusson GN, Ferrari TB, Wichert-Ana L, Duran FL, Martin-Santos R, Simões MV, Bhattacharyya S, Fusar-Poli P, Atakan Z, Filho AS, Freitas-Ferrari MC, McGuire PK, Zuardi AW, Busatto GF, Hallak JEC. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. J Psychopharmacol. 2011;25(1):121-130.  
  1. Crippa J, Zuardi AW, Garrido GEJ, Wichert-Ana L, Guarnieri R, Ferrari L, Azevedo-Marques PM, Hallak JEC, McGuire PK, Busatto GF. Effects of Cannabidiol (CBD) on Regional Cerebral Blood Flow. Neuropsychopharmacology. 2004;29(2):417-426.  
  1. Zuardi AW, Cosme RA, Graeff FG, Guimarães FS. Effects of ipsapirone and cannabidiol on human experimental anxiety. J Psychopharmacol. 1993;7(Suppl 1):82-88.  
  1. Moltke J, Hindocha C. Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on selfperceived stress, anxiety, and sleep problems. J Cannabis Res. 2021;3(1):5.  
  1. Wan B angela, Diaz P, Blake A, Chan S, Wolt A, Zaki P, Zhang L, Slaven M, Shaw E, DeAngelis C, Lam H, Ganesh V, Malek L, Chow E. Efficacy of different varieties of medical cannabis in relieving symptoms. J Pain Manag. 2017;10(4):375-383 
  1. Cahill SP, Lunn SE, Diaz P, Page JE. Evaluation of Patient Reported Safety and Efficacy of Cannabis From a Survey of Medical Cannabis Patients in Canada. Front Public Heal. 2021;9:626853. 
Previous Article Next Article

You must be of legal age in your province of residence to view our content.

Go Back

  • English En
  • Français Fr
  • Better Together
Welcome to Aurora. A family of medical cannabis brands.

Patient Login

Forgot password?

This website uses cookies to enable essential features, please review our Cookie Policy for more information on how to manage and personalize your experience.